In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1857 News Items found
New Study Looks at Low-Dose Radiation That Could Make CAR T Cell Therapy More Effective

A preclinical study published in the journal Molecular Therapy by researchers at Memorial Sloan Kettering (MSK) provides evidence that radiation therapy could improve the efficacy of CAR T cell therapy for solid tumors.
Kenneth Marians and Louis V. Gerstner, Jr.
Q&A
Reflecting on 15 Years of Leadership: An Interview with Outgoing GSK Dean Ken Marians

Meet the man who helped make the Gerstner Sloan Kettering Graduate School of Biomedical Sciences a reality.
Actionable Insight to Raise Breast Health Awareness

Women want to understand and decrease their risk of breast cancer, and Nicole Saphier, MD, Director of Breast Imaging at MSK Monmouth, wants to ensure that women make the right decisions when it comes to their breast health this October, in honor of Breast Cancer Awareness Month, and every day.
Melissa Zinovoy, right, and chief radiation therapist Beeban Natt
In the Clinic
Radiation Greatly Reduces Risk of Recurrence for Women with DCIS, a Type of Noninvasive Breast Cancer

Radiation therapy after surgery can sharply reduce the chance that certain low-risk breast cancers will return.
Molecular biologist Ken Marians and cell biologist Michael Overholtzer
In the News
MSK’s Graduate School Welcomes New Dean, Bids Farewell to Its First

Cell biologist Michael Overholtzer will succeed DNA replication expert Ken Marians.
FDA Expands Use of HPV Vaccine: What It Means in the Fight against Cancer

The US Food and Drug Administration has updated its recommendations for the use of Gardasil 9, the vaccine that protects against human papillomavirus (HPV), to include people age 27 to 45. Previously, Gardasil 9 was only approved for use in those between age nine and 26. 
Confocal microscopic image of mouse lymphedema tissue with staining for immune cells and lymphatic vessels.
In the Lab
Researchers Zero In on the Cause of Lymphedema, a Debilitating Cancer Complication

Learn how an MSK laboratory is bringing much-needed focus to cancer-related lymphedema and investigating new ways to prevent the complication.
Dr. Michel Sadelain, Director of the Center for Cell Engineering, receives the Pasteur Weizmann/Servier Prize at the Academy of Sciences in Paris on October 16, 2018.
World-Renowned Immunologist Michel Sadelain Wins Pasteur-Weizmann/Servier Prize

Michel Sadelain, MD, PhD, Director of the Center for Cell Engineering at MSK, has been awarded the Pasteur-Weizmann/Servier International Prize. Dr. Sadelain was chosen in recognition of his pivotal research demonstrating the therapeutic potential of engineered T cells.
Illustration of liver inside human torso with other organs (intestines) also visible.
Q&A
What’s Behind the Rise in Liver Cancer Deaths — and What Can Be Done About It?

Find out what’s contributing to a marked increase in the death rate for liver cancer.
Gayle Rawlins-Peters and Anastasia Zankow
Feature
Improving the Lives of People with Brain Cancer, Thanks to a New Model for Treatment

Learn more about the Neurology Multidisciplinary Care Clinic, which aims to help people with brain cancer and offer hope for their families.